9 METERS BIOPHARMA INC (NMTR) Stock Analyst Earnings Estimates
NASDAQ:NMTR - Nasdaq - US6544052086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.27M -27.07% | 4.07M -50.79% | 1.88M -53.81% | N/A -100.00% | N/A | 6.375M | -100.00% | 37.09M | 110.89M 198.98% | 207.01M 86.68% | 337.18M 62.88% | 445.15M 32.02% | |||||
| EBITDA YoY % growth | -6.41M | -5.82M 9.20% | -6.53M -12.20% | N/A -178.71% | N/A -40.27% | -63.852M -11.99% | -37.74M -10.71% | -38.421M -32.73% | -14.708M 64.99% | -28.835M -96.05% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.46M 3.29% | -5.95M 7.89% | -6.66M -11.93% | N/A -173.57% | N/A -40.23% | -48.781M -11.98% | -36.59M -10.65% | -41.43M -32.72% | -39.075M 7.00% | -53.221M -36.20% | -44.51M 16.37% | -27.12M 39.07% | 25.059M 192.40% | 92.548M 269.32% | 178.73M 93.12% | 254.78M 42.55% | |
| Operating Margin | -78.11% | -146.19% | -354.26% | N/A | N/A | N/A | N/A | N/A | -612.95% | N/A | N/A | -73.12% | 22.60% | 44.71% | 53.01% | 57.23% | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -106.32% | -11.63 71.94% | -3.09 -2,627.27% | -3.29 -8.00% | -1.35 58.27% | -1.25 7.20% | -1.11 11.87% | 4.71 526.20% | 7.02 48.92% | 7.38 5.23% | 8.65 17.13% | 9.93 14.86% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.59 26.66% | -0.41 43.33% | -0.57 38.19% | -1.14 -12.00% | -1.14 -94.71% | -1.17 -187.50% | -1.13 -99.10% | -1.03 9.82% | -1.04 8.93% | -1.35 -14.78% | -1.18 -4.50% |
| Revenue Q2Q % growth | N/A | N/A | N/A | 2.372M | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.618M 14.09% | -9.749M -11.85% | -8.677M 19.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -1.02 -27.50% | -0.79 | -0.23 | -28.53% |
| Q4 2022 Q2Q % growth | -0.92 -15.00% | -0.78 | -0.14 | -18.34% |
| Q3 2022 Q2Q % growth | -0.72 28.00% | -0.84 | 0.12 | 13.92% |
| Q2 2022 Q2Q % growth | -0.80 -33.33% | -0.85 | 0.05 | 5.89% |
| Q1 2022 Q2Q % growth | -0.80 -33.33% | -0.77 | -0.04 | -4.58% |
| Q4 2021 Q2Q % growth | -0.80 20.00% | -0.73 | -0.07 | -8.93% |
| Q3 2021 Q2Q % growth | -1.00 16.67% | -0.75 | -0.25 | -33.68% |
| Q2 2021 Q2Q % growth | -0.60 | -0.61 | 0.01 | 1.96% |
| Q1 2021 Q2Q % growth | -0.60 | -0.56 | -0.04 | -6.95% |
| Q4 2020 Q2Q % growth | -1.00 | -0.84 | -0.16 | -18.84% |
| Q3 2020 Q2Q % growth | -1.20 76.92% | -1.22 | 0.02 | 1.96% |
| Q3 2019 Q2Q % growth | -5.20 | -2.86 | -2.34 | -82.07% |
| Q2 2019 Q2Q % growth | -2.64 | -2.65 | 0.01 | 0.45% |
| Q1 2019 Q2Q % growth | -3.20 | -2.45 | -0.75 | -30.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.93% | 44.63% | 44.63% |
| Revenue | N/A | N/A | N/A | N/A |